Evolution of tisagenlecleucel use for the treatment of pediatric and young adult relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) registry results Meeting Abstract


Authors: Rouce, R. H.; Baumeister, S. H. C.; Curran, K. J.; Fabrizio, V. A.; Hall, E. M.; Hsieh, E. M.; Karras, N. A.; Keating, A. K.; Moskop, A.; Pasquini, M. C.; Phillips, C. L.; Pulsipher, M. A.; Nuortti, M.; Willert, J.; Ramos, R.; John, S.; Grupp, S. A.
Abstract Title: Evolution of tisagenlecleucel use for the treatment of pediatric and young adult relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) registry results
Meeting Title: 2024 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 16 Suppl.
Meeting Dates: 2024 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001275557402299
PROVIDER: wos
DOI: 10.1200/JCO.2024.42.16_suppl.10016
Notes: Meeting Abstract: 10016 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kevin Joseph Curran
    144 Curran